Form 4: Quest Diagnostics Executive Reports Stock Transaction to Cover Tax Obligations

Michael J. Deppe, SVP, Corp. Controller & CAO of Quest Diagnostics, reported a transaction involving the disposition of common stock to cover tax withholding obligations from vesting restricted stock units.

Summary

• Michael J. Deppe, a senior executive at Quest Diagnostics, filed a Form 4 with the SEC.
• The filing reports a transaction on February 19, 2025, where 99 shares of common stock were disposed of at a price of $169.71 per share.
• This disposition was solely to cover tax withholding obligations arising from the vesting of restricted stock units.
• Following the transaction, Deppe directly owns 35,300 shares of Quest Diagnostics common stock.
• Deppe also indirectly owns 694 shares through the company's 401(k) plan.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing reporting a routine transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard transaction related to tax obligations from vested equity.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on stakeholders as it is a routine sale of shares to cover tax obligations.

Key Dates